• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Sangamo Biosciences Inc. (SGMO)

    -NasdaqGS
    6.67 Up 0.13(1.99%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 39,539   45,870   24,133  
    Cost of Revenue -   -   -  
    Gross Profit 39,539   45,870   24,133  
    Operating Expenses
    Research Development67,198  56,974  37,039  
    Selling General and Administrative19,197  15,677  13,800  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (46,856) (26,781) (26,706)
    Income from Continuing Operations
    Total Other Income/Expenses Net431  364  82  
    Earnings Before Interest And Taxes(46,425)(26,417)(26,624)
    Interest Expense -   -   -  
    Income Before Tax(46,425)(26,417)(26,624)
    Income Tax Expense(5,722) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(40,703)(26,417)(26,624)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (40,703) (26,417) (26,624)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (40,703) (26,417) (26,624)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.